Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 6

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych:  6-hydroxydopamine
help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
To determine whether behavioral sensitization produced by prolonged D-amphetamine administration affects susceptibility of nigrostriatal dopaminergic neurons to the neurotoxic actions of 6-hydroxydopamine (6-OHDA), rats were treated daily from the 23 rd day after birth for 11 consecutive days with D-amphetamine (1.0 mg/kg s.c.) or saline. On the last day of treatment, one group primed with D-amphetamine and one control group of rats were tested to confirm behavioral sensitization development. The remaining animals were additionally treated on the 34 th day (one day after the last D-amphetamine injection) with 6-OHDA HBr (300 µg in 10 µl i.c.v., salt form, half in each lateral ventricle) or its vehicle. Four weeks later the levels of dopamine (DA) and its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), 3-metoxytyramine (3-MT), as well as 5-hydroxytrypatmine (5-HT) and its metabolite 5-hydroxyindoleacteic acid (5-HIAA) were assayed in the striatum, by HPLC/ED. In rats with behavioral sensitization, 6-OHDA reduced endogenous dopamine and its metabolites content to a comparable degree in comparison to controls. This finding indicates that presumed up-regulation of the dopamine transporter in the behaviorially sensitized rats did not increase the neurotoxicity of a high dose of 6-OHDA.
The rat model of Parkinson’s disease (PD) based on experimental impairment of nigrostriatal dopaminergic system by 6-hydroxydopamine (6-OHDA) has been elaborated to study mechanisms of respiratory disturbances associated with PD. Following striatal injection of 6-OHDA breathing with hypoxic mixture augments the hyperventilatory response to hypoxia suggesting an attenuation of the depressant effect of dopamine on ventilation. In the present study we ask whether injection of 6-OHDA into the medial forebrain bundle (MFB), that evokes more severe motor symptoms, elicits changes in the hypoxic ventilatory response and whether changes in ventilatory response to hypoxia following the unilateral dopaminergic denervation are transmitted by peripheral dopamine D2 receptors. The experiments were performed on adult rats. Ventilatory parameters: tidal volume, minute ventilation, and frequency of breathing were measured with the use of body plethysmograph method before and two weeks following unilateral, double injection of 6-OHDA into the MFB. Changes in the body weight and behavioral cylinder test were evaluated at the same time points and compared with the results obtained in sham operated rats. Effects of peripheral dopamine D2 receptor antagonist, domperidone (1 mg/ kg i.p.) on ventilation during rest breathing and during 3 minutes exposure to hypoxia (8% O2)were studied before and after 6-OHDA injection. Two weeks after 6-OHDA treatment the cylinder test showed limb use asymmetry. Body weight increased less than in animals without 6-OHDA injection. Following the MFB lesion the hyperventilatory response to hypoxia was augmented mainly by an increment of tidal volume. Before the MFB lesion the pretreament with domperidone enhanced resting ventilation and hypoxic hyperventilatory response. After 6-OHDA injection domperidone no longer altered both normoxic breathing and the hyperventilatory hypoxic response. The study shows that an impairment of dopaminergic system by MFB lesion causes comparable changes in breathing and ventilatory response to hypoxia as lesions in the other locations of the nigrostriatal pathways. In 6-OHDA model of Parkinson’s disease changes in the hypoxic ventilatory response seem to be related to a reduction of peripheral D2 dopaminergic neurotransmission involved in the control of breathing.
Degeneration of dopaminergic nigrostriatal pathway is generally accepted to be a cause of Parkinson’s disease (PD) motor symptoms such as akinesia, bradykinesia and tremor. Unfortunately the extent of the degeneration does not correlate with tremor occurrence and intensity, therefore cannot explain sufficiently its appearance. Mechanisms leading to induction of tremor are still not explained. Interestingly, image analysis studies have suggested contribution of an increased activity of the cerebellum to the PD tremor. The aim of the present study was to examine whether a selective, partial lesion of dopaminergic structures – the substantia nigra pars compacta (SNc, A9) and retrorubral field (RRF, A8) would influence the tremor behaviour induced by harmaline. Harmaline model of tremor induces an abnormal synchronous activation of the climbing glutamatergic olivo-cerebellar pathway and cerebellar Purkinje cells. 6-OHDA (8 mg /2 ml) was injected unilaterally into the region of the posterior part of the SNc and RRF to induce moderate size of degeneration, similar to early PD. Harmaline was administered in a dose of 7.5 mg/kg i.p. on the 8th day after the operation and tremor of forelimbs, head and trunk was measured. In precise behavioural studies we have found that the lesion of dopaminergic system increased intensity of the tremor induced by harmaline but did not influence its character. Stereological examination of the lesion extent revealed losses of dopaminergic (tyrosine hydroxylase-immunoreactive) neurons in the anterior (30%) and posterior (72%) SNc, as well as in RRF (72% on the average). Levels of dopamine and all its metabolites, as well as noradrenaline concentrations on ipsilateral to lesioned side were moderately decreased in the caudate-putamen, while, dopamine and DOPAC in the anterior cerebellum were increased. In the caudate-putamen, the ipsi/contra ratio of dopamine level correlated negatively, while that of dopamine turnover positively with the tremor intensity. However, in the anterior cerebellum an inverse relationship was found. Moreover, this symptom correlated positively with serotonin level and negatively with the 5-HIAA/serotonin ratio on the contralateral side of the posterior cerebellum. The presented results indicate that modulation of dopaminergic and serotonergic transmissions by the dopaminergic system lesion, modelling early stages of PD, may influence cerebellar mechanisms triggering tremor. The study was supported by the grant of the Ministry of Science and Higher Education No N_N401_570638 and by Statutory Funds of the Department of Neuropsychopharmacology, Institute of Pharmacology, Polish Academy of Sciences, Cracow, Poland
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.